Aqua Medical Names Bob Haggerty CEO to Take on Type 2 Diabetes
The MedTech veteran who scaled 1RF ablation for Barrett’s Esophagus into a $40 million business takes the helm as Aqua treats its first patient in the U.S. pilot study of PIMA for type 2 diabetes. PLEASANTON, Calif., Aug. 4, 2026 /PRNewswire/ — Aqua Medical, Inc., a clinical-stage medical device company developing minimally invasive endoscopic therapies for type […]